Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Tabata

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Pharmacological Sciences|April 4, 2015
Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factorsKentaro Minami, Yoshinari Shinsato, Masatatsu Yamamoto, et al.
Nature Communications|December 5, 2015
Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumabAtsushi Mitsuhashi, Hisatsugu Goto, Atsuro Saijo, et al.
Biochemical and Biophysical Research Communications|April 2, 2026
Polypharmacologic phosphoinositide modulation by FTY720 triggers endomembrane trafficking collapse and metabolic starvation in cancer cellsSatoshi Kofuji, Kazutaka Sumita, Yoshiki Ikeda, et al.
Experimental Cell Research|August 2, 2008
Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cellsRyuji Ikeda, Ken-ichi Iwashita, Tomoyuki Sumizawa, et al.
Cell Reports|May 18, 2017
Thymidine Catabolism as a Metabolic Strategy for Cancer SurvivalSho Tabata, Masatatsu Yamamoto, Hisatsugu Goto, et al.
Scientific Reports|May 2, 2018
Thymidine catabolism promotes NADPH oxidase-derived reactive oxygen species (ROS) signalling in KB and yumoto cellsSho Tabata, Masatatsu Yamamoto, Hisatsugu Goto, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2017
Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYCKiyotoshi Satoh, Shinichi Yachida, Masahiro Sugimoto, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Pharmacological Sciences|April 4, 2015
Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factorsKentaro Minami, Yoshinari Shinsato, Masatatsu Yamamoto, et al.
Nature Communications|December 5, 2015
Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumabAtsushi Mitsuhashi, Hisatsugu Goto, Atsuro Saijo, et al.
Biochemical and Biophysical Research Communications|April 2, 2026
Polypharmacologic phosphoinositide modulation by FTY720 triggers endomembrane trafficking collapse and metabolic starvation in cancer cellsSatoshi Kofuji, Kazutaka Sumita, Yoshiki Ikeda, et al.
Experimental Cell Research|August 2, 2008
Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cellsRyuji Ikeda, Ken-ichi Iwashita, Tomoyuki Sumizawa, et al.
Cell Reports|May 18, 2017
Thymidine Catabolism as a Metabolic Strategy for Cancer SurvivalSho Tabata, Masatatsu Yamamoto, Hisatsugu Goto, et al.
Scientific Reports|May 2, 2018
Thymidine catabolism promotes NADPH oxidase-derived reactive oxygen species (ROS) signalling in KB and yumoto cellsSho Tabata, Masatatsu Yamamoto, Hisatsugu Goto, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2017
Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYCKiyotoshi Satoh, Shinichi Yachida, Masahiro Sugimoto, et al.
Pageof 5